JPWO2020163785A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020163785A5 JPWO2020163785A5 JP2021546285A JP2021546285A JPWO2020163785A5 JP WO2020163785 A5 JPWO2020163785 A5 JP WO2020163785A5 JP 2021546285 A JP2021546285 A JP 2021546285A JP 2021546285 A JP2021546285 A JP 2021546285A JP WO2020163785 A5 JPWO2020163785 A5 JP WO2020163785A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hypnotic
- muscular
- nri
- atomoxetine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025016270A JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803223P | 2019-02-08 | 2019-02-08 | |
| US62/803,223 | 2019-02-08 | ||
| PCT/US2020/017323 WO2020163785A1 (en) | 2019-02-08 | 2020-02-07 | Methods and compositions for treating sleep apnea |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016270A Division JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022519721A JP2022519721A (ja) | 2022-03-24 |
| JPWO2020163785A5 true JPWO2020163785A5 (https=) | 2023-02-15 |
| JP2022519721A5 JP2022519721A5 (https=) | 2023-02-15 |
| JP7705348B2 JP7705348B2 (ja) | 2025-07-09 |
Family
ID=71947080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546285A Active JP7705348B2 (ja) | 2019-02-08 | 2020-02-07 | 睡眠時無呼吸を治療するための方法および組成物 |
| JP2025016270A Pending JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025016270A Pending JP2025084754A (ja) | 2019-02-08 | 2025-02-03 | 睡眠時無呼吸を治療するための方法および組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12558327B2 (https=) |
| EP (2) | EP4635514A3 (https=) |
| JP (2) | JP7705348B2 (https=) |
| KR (1) | KR20210125507A (https=) |
| CN (2) | CN118557736A (https=) |
| AU (2) | AU2020219809B2 (https=) |
| BR (1) | BR112021015600A2 (https=) |
| CA (1) | CA3129270A1 (https=) |
| EA (1) | EA202192202A1 (https=) |
| ES (1) | ES3049086T3 (https=) |
| IL (1) | IL285197A (https=) |
| MX (2) | MX2021009407A (https=) |
| MY (1) | MY210043A (https=) |
| PH (1) | PH12021551850A1 (https=) |
| SG (1) | SG11202108225QA (https=) |
| UA (1) | UA130366C2 (https=) |
| WO (1) | WO2020163785A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3746126B1 (en) | 2018-01-30 | 2024-07-31 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea or simple snoring |
| EP4635514A3 (en) | 2019-02-08 | 2025-12-24 | The Brigham & Women's Hospital, Inc. | Methods and compositions for treating sleep apnea |
| GEAP202416361A (en) * | 2021-03-24 | 2024-04-25 | Apnimed Inc Delaware | Methods and compositions for treating sleep apnea |
| KR20240021920A (ko) * | 2021-06-17 | 2024-02-19 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 노르에피네프린 재흡수 억제제 |
| US20250302814A1 (en) * | 2022-05-13 | 2025-10-02 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| CN119789855A (zh) * | 2022-09-02 | 2025-04-08 | 爱普宁公司(特拉华) | 治疗睡眠呼吸暂停的方法和组合物 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP1191930A2 (en) | 1999-05-20 | 2002-04-03 | Sepracor Inc. | Methods for treatment of asthma using s-oxybutynin |
| PT1257277E (pt) | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| US20020155113A1 (en) | 2001-03-13 | 2002-10-24 | Miyoung Chun | Methods for treating or preventing cardiovascular disorders by modulating metalloprotease function |
| US20030185882A1 (en) | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| US20040235925A1 (en) | 2002-12-17 | 2004-11-25 | Pharmacia Corporation | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof |
| CA2566154A1 (en) | 2004-05-27 | 2005-12-08 | Warner-Lambert Company Llc | Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders |
| US20060039867A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders with setiptiline |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
| KR20070087678A (ko) | 2004-12-20 | 2007-08-28 | 컬리지움 파마슈티칼, 인코포레이티드 | 수면 장애용 약제 조성물 |
| FR2889811B1 (fr) | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| ES2610508T3 (es) | 2006-11-22 | 2017-04-27 | Clinical Research Associates, Llc | Métodos para tratar el síndrome de Down, el síndrome del cromosoma X frágil y el autismo |
| WO2008122019A1 (en) | 2007-04-02 | 2008-10-09 | Cypress Biosciences, Inc. | Improving the tolerability of both mirtazapine and reboxetine by using them in combination |
| EP2455076A1 (en) * | 2007-04-09 | 2012-05-23 | Sepracor Inc. | Compositions comprising desvenlafaxine for use in treating sleep-related breathing disorders |
| EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
| CN101925349A (zh) * | 2007-12-21 | 2010-12-22 | 欧兰德股份有限公司 | 替马西泮的口腔崩解片组合物 |
| US20100204058A1 (en) | 2009-01-28 | 2010-08-12 | Howard Yuan-Hao Chang | Profiling for Determination of Response to Treatment for Inflammatory Disease |
| CA2825309C (en) | 2011-01-28 | 2019-10-01 | Pfantastic Medical Research Institute, Llc | Pyridostigmine for the treatment of obstructive sleep apnea |
| WO2016062279A1 (zh) | 2014-10-24 | 2016-04-28 | 朗齐生物医学股份有限公司 | 苹果酸丙氯陪拉辛锭用于制备治疗癌症药物的用途 |
| DK3288946T3 (da) * | 2015-04-27 | 2019-11-25 | Arena Pharm Inc | 5-ht2c-receptoragonister og sammensætninger og anvendelsesfremgangsmåder |
| WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
| ES2925951T3 (es) | 2015-07-22 | 2022-10-20 | John Hsu | Composición que comprende un agente terapéutico y un estimulante respiratorio y métodos para su uso |
| AU2018260666B2 (en) | 2017-04-28 | 2022-07-21 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treating sleep apnea |
| EP3746126B1 (en) | 2018-01-30 | 2024-07-31 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea or simple snoring |
| EP4635514A3 (en) | 2019-02-08 | 2025-12-24 | The Brigham & Women's Hospital, Inc. | Methods and compositions for treating sleep apnea |
-
2020
- 2020-02-07 EP EP25200289.4A patent/EP4635514A3/en active Pending
- 2020-02-07 KR KR1020217027063A patent/KR20210125507A/ko active Pending
- 2020-02-07 CN CN202410525932.1A patent/CN118557736A/zh active Pending
- 2020-02-07 BR BR112021015600-3A patent/BR112021015600A2/pt unknown
- 2020-02-07 CA CA3129270A patent/CA3129270A1/en active Pending
- 2020-02-07 EP EP20752195.6A patent/EP3920898B1/en active Active
- 2020-02-07 SG SG11202108225QA patent/SG11202108225QA/en unknown
- 2020-02-07 ES ES20752195T patent/ES3049086T3/es active Active
- 2020-02-07 MX MX2021009407A patent/MX2021009407A/es unknown
- 2020-02-07 CN CN202080026282.6A patent/CN113692277B/zh active Active
- 2020-02-07 WO PCT/US2020/017323 patent/WO2020163785A1/en not_active Ceased
- 2020-02-07 JP JP2021546285A patent/JP7705348B2/ja active Active
- 2020-02-07 AU AU2020219809A patent/AU2020219809B2/en active Active
- 2020-02-07 PH PH1/2021/551850A patent/PH12021551850A1/en unknown
- 2020-02-07 UA UAA202104441A patent/UA130366C2/uk unknown
- 2020-02-07 MY MYPI2021004502A patent/MY210043A/en unknown
- 2020-02-07 EA EA202192202A patent/EA202192202A1/ru unknown
- 2020-02-07 US US17/428,596 patent/US12558327B2/en active Active
-
2021
- 2021-07-28 IL IL285197A patent/IL285197A/en unknown
- 2021-08-04 MX MX2025004365A patent/MX2025004365A/es unknown
-
2025
- 2025-02-03 JP JP2025016270A patent/JP2025084754A/ja active Pending
- 2025-07-15 AU AU2025205464A patent/AU2025205464A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2378255T3 (es) | Titulación de tapentadol | |
| JP2025084754A5 (https=) | ||
| ES2226435T3 (es) | Metodos de uso y composiciones que comprenden inhibidores de la recaptacion de dopamina. | |
| US8729070B2 (en) | CNS pharmaceutical compositions and methods of use | |
| CA2716080C (en) | Cns pharmaceutical compositions and methods of use | |
| US20060039867A1 (en) | Method for treating sleep-related breathing disorders with setiptiline | |
| US20160081938A1 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| AU2011231645A1 (en) | Fast dissolving drug delivery systems | |
| US20110237563A1 (en) | Fast dissolving drug delivery systems | |
| US20100160294A1 (en) | Tolerability of mirtazapine and a second active by using them in combination | |
| JP2005531631A (ja) | 禁煙促進方法 | |
| AU2018290889B2 (en) | NK-1 antagonist compositions and methods for use in treating depression | |
| ES2260195T3 (es) | Metodos de producir (r)-y (s)-didesmetil-sibutramina opticamente pura. | |
| TW200831097A (en) | Treatment of anxiety with eszopiclone | |
| US20090275562A1 (en) | Tolerability of mirtazapine and a second active by using them in combination | |
| JP2008533142A (ja) | α７ニューロンニコチン性受容体リガンドおよび抗精神病薬組成物 | |
| CN113453683A (zh) | 运动障碍的治疗 | |
| JP2022506113A5 (https=) | ||
| JPWO2020163785A5 (https=) | ||
| JP2004529850A (ja) | 性機能不全の処置および防止のための方法および組成物 | |
| RU2358719C2 (ru) | Композиции, содержащие ингибиторы обратного захвата допамина, и способы их применения | |
| WO2011008686A1 (en) | Exo-s-mecamylamine method, use, and compound for treatment | |
| CN101247810A (zh) | 催眠药与R(+)-α-(2,3-二甲氧基-苯基)-1-[2-(4-氟苯基)乙基]-4-哌啶甲醇的组合及其治疗应用 |